Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Crowther

Showing results (31-40 of 286) with videos related to

Pageof 29
Sort By:
Kardiologia Polska|October 20, 2018
How can we reverse bleeding in patients on direct oral anticoagulants?Mark Crowther, Adam Cuker
Expert Review of Hematology|October 10, 2018
Andexanet alfa for the treatment of hemorrhageAndrea Cervi, Mark Crowther
Polskie Archiwum Medycyny Wewnetrznej|August 28, 2007
[Fondaparinux--evolution or revolution in anticoagulant care?]Mark Crowther, Wendy Lim
European Journal of Internal Medicine|June 12, 2020
The value of bleeding scores in the assessment of patients presenting with bleeding of unknown cause: Complex algorithms with little predictive valueLynn Malec, Mark Crowther
Case Reports in Hematology|July 28, 2025
A Hyperacute Presentation of Small Cell, Non-Nodal Mantle Cell LymphomaJodi Chiu, Mark Crowther
Thrombosis and Haemostasis|September 1, 2010
Venous thromboembolism, age and hospitalisation: A potentially deadly combinationFrancesco Dentali, Mark Crowther
Thrombosis Research|October 6, 2010
Management of deep vein thrombosis diagnosed during active labourShari Ghanny, Mark Crowther
Thrombosis Research|August 13, 2004
Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failureFinn Wisløff, Mark Crowther
Obstetrics and Gynecology Clinics of North America|September 12, 2006
Acquired thrombophilia during pregnancyFrancesco Dentali, Mark Crowther
Current Opinion in Hematology|July 16, 2013
Treatment with novel oral anticoagulants: indications, efficacy and risksShari Ghanny, Mark Crowther
Pageof 29

Showing results (31-40 of 286) with videos related to

Sort By:
Pageof 29
Kardiologia Polska|October 20, 2018
How can we reverse bleeding in patients on direct oral anticoagulants?Mark Crowther, Adam Cuker
Expert Review of Hematology|October 10, 2018
Andexanet alfa for the treatment of hemorrhageAndrea Cervi, Mark Crowther
Polskie Archiwum Medycyny Wewnetrznej|August 28, 2007
[Fondaparinux--evolution or revolution in anticoagulant care?]Mark Crowther, Wendy Lim
European Journal of Internal Medicine|June 12, 2020
The value of bleeding scores in the assessment of patients presenting with bleeding of unknown cause: Complex algorithms with little predictive valueLynn Malec, Mark Crowther
Case Reports in Hematology|July 28, 2025
A Hyperacute Presentation of Small Cell, Non-Nodal Mantle Cell LymphomaJodi Chiu, Mark Crowther
Thrombosis and Haemostasis|September 1, 2010
Venous thromboembolism, age and hospitalisation: A potentially deadly combinationFrancesco Dentali, Mark Crowther
Thrombosis Research|October 6, 2010
Management of deep vein thrombosis diagnosed during active labourShari Ghanny, Mark Crowther
Thrombosis Research|August 13, 2004
Evidence-based treatment of the antiphospholipid syndrome: I. Pregnancy failureFinn Wisløff, Mark Crowther
Obstetrics and Gynecology Clinics of North America|September 12, 2006
Acquired thrombophilia during pregnancyFrancesco Dentali, Mark Crowther
Current Opinion in Hematology|July 16, 2013
Treatment with novel oral anticoagulants: indications, efficacy and risksShari Ghanny, Mark Crowther
Pageof 29